Center-Authored Papers

Filters: Author is Self, Steven G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
Liu MKP, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M et al..  2013.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.. The Journal of clinical investigation. 123(1):380-93. Abstract
Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ et al..  2015.  Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conserved regions (HVTN 083).. The Journal of infectious diseases. Abstract
U
Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu S-lok, Johnson PR et al..  2008.  The use of nonhuman primate models in HIV vaccine development.. PLoS medicine. 5(8):e173.
T
Hawn TR, Day TA, Scriba TJ, Hatherill M, Hanekom WA, Evans TG, Churchyard GJ, Kublin JG, Bekker L-G, Self SG.  2014.  Tuberculosis vaccines and prevention of infection.. Microbiology and molecular biology reviews : MMBR. 78(4):650-71. Abstract
Li F, McKenney DM, Malhotra U, Crimi C, Nolin J, Corey L, McElrath MJ, Newman MJ, Self SG.  2008.  Towards prediction of degenerate CTL epitope recognition.. Human vaccines. 4(2):115-21. Abstract
Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG et al..  2010.  Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.. Journal of virology. 84(3):1439-52. Abstract
Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK et al..  2014.  Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus.. Cancer prevention research (Philadelphia, Pa.). 7(1):114-27. Abstract
S
Asbach B, Kliche A, Köstler J, Perdiguero B, Esteban M, Jacobs BL, Montefiori DC, Labranche CC, Yates NL, Tomaras GD et al..  2016.  Streamlining Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.. Journal of virology. Abstract
Huang Y, Gilbert PB, Montefiori DC, Self SG.  2009.  Simultaneous Evaluation of the Magnitude and Breadth of a Left and Right Censored Multivariate Response, with Application to HIV Vaccine Development.. Statistics in biopharmaceutical research. 1(1):81-91. Abstract
Gilbert PB, Grove D, Gabriel E, Huang Y, Gray G, Hammer SM, Buchbinder SP, Kublin J, Corey L, Self SG.  2012.  A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens. Statistical Communications in Infectious Diseases. 3(1)
Nicholson O, Dicandilo F, Kublin J, Sun X, Quirk E, Miller M, Gray G, Pape J, Robertson MN, Mehrotra DV et al..  2011.  Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.. AIDS research and human retroviruses. 27(5):557-567. Abstract
R
Gilbert PB, Qin L, Self SG.  2009.  Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'.. Statistics in medicine. 28(4):716-9.
Ferrari G, Korber B, Goonetilleke N, Liu MKP, Turnbull EL, Salazar-Gonzalez JF, Hawkins N, Self SG, Watson S, Betts MR et al..  2011.  Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.. PLoS pathogens. 7(2):e1001273. Abstract
P
Barouch DH, Liu J, Lynch DM, O'Brien KL, La Porte A, Simmons NL, Riggs AM, Clark S, Abbink P, Montefiori DC et al..  2009.  Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys.. Journal of virology. 83(18):9584-90. Abstract
Hudgens MG, Gilbert PB, Mascola JR, Wu C-D, Barouch DH, Self SG.  2009.  Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments.. The Journal of infectious diseases. 200(4):609-13. Abstract
O
Donaldson MM, Kao S-F, Eslamizar L, Gee C, Koopman G, Lifton M, Schmitz JE, Sylwester AW, Wilson A, Hawkins N et al..  2012.  Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies.. Journal of immunological methods. 386(1-2):10-21. Abstract
Corbett NP, Blimkie D, Ho KC, Cai B, Sutherland DP, Kallos A, Crabtree J, Rein-Weston A, Lavoie PM, Turvey SE et al..  2010.  Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells.. PloS one. 5(11):e15041. Abstract
N
Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, Lavoie PM, Furlong J, Fortuno ES, Hajjar AM et al..  2009.  Neonatal innate TLR-mediated responses are distinct from those of adults.. Journal of immunology (Baltimore, Md. : 1950). 183(11):7150-60. Abstract
M
Boily M-C, Abu-Raddad L, Desai K, Masse B, Self SG, Anderson R.  2008.  Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
Li F, Finnefrock AC, Dubey SA, Korber BTM, Szinger J, Cole S, McElrath MJ, Shiver JW, Casimiro DR, Corey L et al..  2011.  Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the step study.. PloS one. 6(6):e20479. Abstract
Montefiori DC, Karnasuta C, Huang Y, Ahmed H, Gilbert P, de Souza MS, McLinden R, Tovanabutra S, Laurence-Chenine A, Sanders-Buell E et al..  2012.  Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials.. The Journal of infectious diseases. 206(3):431-41. Abstract
Gilbert PB, Wang M, Wrin T, Petropoulos C, Gurwith M, Sinangil F, D'Souza P, Rodriguez-Chavez IR, DeCamp A, Giganti M et al..  2010.  Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.. The Journal of infectious diseases. 202(4):595-605. Abstract
L
Chen X, Chen J-shan, Zhang L, Li J-guang, Yao L, Self SG, Sun X, Tang N-jun.  2015.  Levels of PCDDs, PCDFs and dl-PCBs in the blood of childbearing-aged women living in the vicinity of a chemical plant in Tianjin: a primary study.. Chemosphere. 118:1-4. Abstract
I
Tomaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, Decamp AC, Parks RJ, Ashley VC, Lucas JT et al..  2008.  Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.. Journal of virology. 82(24):12449-63. Abstract
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody AM, Ferrari G, Weinhold KJ, Miller SE et al..  2008.  Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.. Journal of virology. 82(15):7700-10. Abstract